Brown, Nicholas F.
Ng, Stasya M.
Brooks, Claire
Coutts, Tim
Holmes, Jane
Roberts, Corran
Elhussein, Leena
Hoskin, Peter
Maughan, Tim
Blagden, Sarah
Mulholland, Paul https://orcid.org/0000-0002-7926-824X
Funding for this research was provided by:
The National Brain Appeal (NBA/IpiGlio)
Bristol-Myers Squibb
Article History
Received: 19 November 2019
Accepted: 11 February 2020
First Online: 12 March 2020
Ethics approval and consent to participate
: This study will be conducted in accordance with the Declaration of Helsinki, the principles of Good Clinical Practice, and applicable clinical trials regulations. Study conduct is approved by the South Central (Oxford B) Research Ethics Committee (18/SC/0525) and the Medicines and Healthcare Regulatory Agency. All patients will provide written informed consent prior to participation in the trial. The clinical sites are Addenbrooke’s Hospital (Cambridge University Hospitals NHS Foundation Trust), The Christie (The Christie NHS Foundation Trust), Churchill Hospital (Oxford University Hospitals NHS Foundation Trust), Guy’s Hospital (Guy’s and St Thomas’ NHS Foundation Trust), Mount Vernon Cancer Centre (The Hillingdon Hospitals NHS Foundation Trust), University College Hospital (University College London Hospitals NHS Foundation Trust), and Western General Hospital (NHS Lothian).
: Not applicable.
: The authors declare that they have no competing interests.